Abstract
A novel series of 4,6-diaryl-2-aminopyrimidines 8a–o has been synthesized and evaluated for in vitro antiplasmodial activity against Plasmodium falciparum. Out of the 15 compounds synthesized and tested, 6 compounds have shown IC50 values in the range of 1.61–9.53 μg/mL. These compounds are several times more potent than chloroquine and quinine, the two standard drugs used for the purpose of comparison.
Similar content being viewed by others
References
Agarwal A, Srivastava K, Puri SK, Chauhan PMS (2005a) Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents. Bioorg Med Chem 13:6226–6232
Agarwal A, Srivastava K, Puri SK, Chauhan PMS (2005b) Synthesis of 2,4,6-trisubstituted pyrimidines as antimalarial agents. Bioorg Med Chem 13:4645–4650
Agarwal A, Srivastava K, Puri SK, Sinha S, Chauhan PMS (2005c) A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents. Bioorg Med Chem Lett 15:5218–5221
Baker W (1933) 322. Molecular rearrangement of some o-acyloxyacetophenones and the mechanism of the production of 3-acylchromones. J Chem Soc (resumed) 1381–1389
Falco EA, Goodwin LG, Hitchings GH, Rollo IM, Russell PB (1951) 2,4-diamino-pyrimidines—a new series of antimalarials. Br J Pharmacol Chemother 6:185–200
Giridhar R, Tamboli RS, Ramajayam R, Prajapati DG, Yadav MR (2012) Assessment of antiplatelet activity of 2-aminopyrimidines. Eur J Med Chem 50:428–432
Glide, version 5.5, (2009) Schrödinger, LLC, New York, NY
Gregson A, Plowe CV (2005) Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev 57:117–145
Hyde JE (2007) Drug-resistant malaria—an insight. FEBS J 274:4688–4698
Karle JM, Karle IL, Gerena L, Milhous WK (1992) Stereochemical evaluation of the relative activities of the cinchona alkaloids against Plasmodium falciparum. Antimicrob Agents Chemother 36:1538–1544
Marder M, Viola H, Bacigaluppo JA, Colombo MI, Wasowski C, Wolfman C, Medina JH, Rúveda EA, Paladini AC (1998) Detection of benzodiazepine receptor ligands in small libraries of flavone derivatives synthesized by solution phase combinatorial chemistry. Biochem Biophys Res Commun 249:481–485
Mishra R, Mishra B, Moorthy NS (2006) Dihydrofolate reductase enzyme: a potent target for antimalarial research. Asian J Cell Biol 1:48–58
Mui EJ, Schiehser GA, Milhous WK, Hsu H, Roberts CW, Kirisits M, Muench S, Rice D, Dubey JP, Fowble JW, Rathod PK, Queener SF, Liu SR, Jacobus DP, McLeod R (2008) Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl Trop Dis 2:e190
Ramajayam R, Giridhar R, Yadav MR, De Clercq E, Pannecouque C, Prajapati DG (2005) Identification of novel non-nucleoside reverse transcriptase inhibitors using fragment-based lead generation. Med Chem Res 14:475–487
Ramajayam R, Giridhar R, Yadav MR, Balaraman R, Djaballah H, Shum D, Radu C (2008) Synthesis, antileukemic and antiplatelet activities of 2,3-diaryl-6,7-dihydro-5H-1,4-diazepines. Eur J Med Chem 43:2004–2010
Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrell R, Lowe G, Thebtaranonth Y, Yuthavong Y (2000) Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance. Bioorg Med Chem 8:1117–1128
Ridley RG (2002) Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 415:686–693
Rollo IM (1975) Antiplasmodial efficacy of 2,4-diaminopyrimidine-sulfonamide combinations, especially against chloroquine-resistant malaria. Can Med Assoc J 112:50–53
Sirichaiwat C, Intaraudom C, Kamchonwongpaisan S, Vanichtanankul J, Thebtaranonth Y, Yuthavong Y (2004) Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum. J Med Chem 47:345–354
Snow RW, Guerra CA, Noor AM, Myint HY, Hay HI (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214–215
Soni S, Gupta S (2009) In vitro antiplasmodial activity of Enicostemma littorale. Am J Infect Dis 5:259–262
Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193:673–675
Tripathi RP, Mishra RC, Dwivedi N, Tewari N, Verma SS (2005) Current status of malaria control. Curr Med Chem 12:2643–2659
Vanichtanankul J, Taweechai S, Yuvaniyama J, Vilaivan T, Chitnumsub P, Kamchonwongpaisan S, Yuthavong Y (2011) Trypanosomal dihydrofolate reductase reveals natural antifolate resistance. ACS Chem Biol 6:905–911
Warhurst DC (1998) Antimalarial drug discovery: development of inhibitors of dihydrofolate reductase active in drug resistance. Drug Discov Today 3:538–546
Wells TNC (2010) Microbiology. Is the tide turning for new malaria medicines? Science 329:1153–1154
World Malaria Report 2011-Fact sheet, Global Malaria Programme, World Health Organisation, Geneva, December 13, 2011
Yuthavong Y (2002) Basis for antifolate action and resistance in malaria. Microbes Infect 4:175–182
Acknowledgments
We thank All India Council for Technical Education (AICTE), New Delhi, India, for financial support in the form of Research Promotion Scheme [File No. 8023/RID/RPS/46/2004e05] to RG and National Doctoral Fellowship to RST [File No. 1–10/RID/NDF/PG/36/2009–2010].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giridhar, R., Tamboli, R.S., Prajapati, D.G. et al. Synthesis of novel 4,6-diaryl-2-aminopyrimidines as potential antiplasmodial agents. Med Chem Res 22, 3309–3315 (2013). https://doi.org/10.1007/s00044-012-0328-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-012-0328-z